HEALTHCARE SERVICES MARKET UPDATE SPRING 2018

Similar documents
HEALTHCARE SERVICES MARKET UPDATE FALL 2017

Healthcare Products & Services Industry Update Q2 2017

IT & PROFESSIONAL SERVICES MARKET UPDATE MARCH 2018

VALUATION TRENDS 18.8

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

HEALTHCARE ADVISORY SERVICES

Purvi B. Maniar Member of the Firm

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SPOTLIGHT PRIVATE EQUITY ACTIVITY INTRO TO PE DEALS VALUATION METRICS SPOT ON TESTING, INSPECTION & CERTIFICATION

Revenue of $100 million to $1 billion and EBITDA in excess of $20 million

Revenue of $100 million to $1 billion and EBITDA in excess of $20 million

Quarterly M&A Report Q1 2012

Lehigh University Team biographies. October 30, 2017

Strong Equity Support

MANAGING DIRECTOR 360 MADISON AVENUE NEW YORK, NY

Healthcare M&A Report Q4 2017

Overview of Venture Equity

Experienced. Focused. Reliable.

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Comprehensive Research Services

Q&A with Jaime Hildreth

Life Sciences & Healthcare Venture Summit. Funding Healthcare & IT Media October 27, 2009

Healthcare Focus. Trends in Capital Flows into Healthcare

HOME OVERVIEW APPROACH PRINCIPALS TRANSACTIONS CONTACT

Mara H. Rogers, Partner Norton Rose Fulbright

Paragon Ventures. Healthcare Mergers and Strategic Acquisitions

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Robert A. Greising Partner

January Bob DeSutter Managing Director Co-Head of Health Care

Robert A. Greising Partner

Chartwell Introduction and AEC Capabilities

in Today s Environment North Atlanta Chapter, GSCPA s

Raymond A. Snead, Jr., D. Sc., FHFMA, FACHE

PART 2B FORM ADV. Updated November 4, 2015 LASALLE INVESTMENT MANAGEMENT, INC. 333 WEST WACKER DRIVE, SUITE 2300 CHICAGO, ILLINOIS 60606

Private Equity Market Update. February 2013

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Venture Capital Search Highlights

WILSON SONSINI GOODRICH & ROSATI

Venture Capital Report

Life Sciences Tools, Diagnostics, & Services Q Industry Overview

4 th Quarter Earnings Conference Call

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

Life Sciences Outlook. New York City 2016

Ewing Bemiss & Co. Investment Banking Analyst Recruiting. Experience Professionalism Results

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fortis to acquire strategic stake in Parkway Holdings, Singapore

Do Mid-Cap Private Equity Funds Have an Advantage in Today s Markets?

Established in 1934, Migdal is the leading insurance and finance group in Israel

Provident Perspectives: Consolidation in Anesthesia

NIRI Virtual Chapter. PROGRAM II September 19, Impact of Private Equity Investors in the Public Markets

Management to Host Conference Call at 8:30 a.m. ET today

Mr. Ross is a graduate of the University of Illinois with bachelor degrees in both accounting and electrical engineering.

MANAGEMENT TEAM FOCUS

Quarterly M&A Report Q3 2018

First Southern Securities, LLC Credentials

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

TEAM CAPABILITIES MUMBAI DELHI (NCR) BANGALORE KOLKATA INDIA

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

CORPORATE PROFILE.

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

W. Kenneth Davis, Jr.

MANAGEMENT TEAM FOCUS

HFMA Summer Conference

ASX: UCW FULL YEAR RESULTS FOR THE YEAR ENDED 30 JUNE 2017

Sonic Expands into USA Pathology Market Acquisition of Interest in CPL

PANEL DISCUSSION & ROUNDTABLES

Boundaryless Hospital - Rethink and Redefine Health Care Management. New Chains of Value Creation

Health Care Expert Panel Bios

Titan s highest priority is helping our companies grow and thrive. As a team, we believe this is best achieved through:

Promoting Foreign Direct Investment in The United States. Christopher Clement International Investment Specialist Invest in America

Life Sciences Outlook. Westchester County 2016

Growth and Complexity of Real Estate

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

2018 J.P. MORGAN HEALTHCARE CONFERENCE

Master Class : Excellence in Private Equity & Deal Structuring

Deals and Dealmakers. The Health Care M&A Review Fourth Quarter 2017

Life Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research

About Us. Sterling Capital is a China centric boutique M&A firm with extensive on the ground China experience since 2003.

An Experienced Approach to Private Equity

Clare Capital. Credentials

Chaired by: Keith Gregg, MBA, CLP, Chairman, JRG VENTURES and Entrepreneur-in- Residence for Health Technology, NASHVILLE ENTREPRENEUR CENTER

Aqua Pharmaceuticals, LLC

Seale & Associates Creative Solutions. Trusted Advice. MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE

COLLABORATIVE CREATIVE LONG-TERM EXPERIENCED VALUE ADDED HIGH INTEGRITY

Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012

Capstone Partners. Medical Device Outsourcing. Market Intelligence for Business Owners Q Coverage Report. Investment Banking Advisors

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

HFMA January CFO Forum

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

Software and IT Industry Market Update: I ll Buy! Is Private Equity Coming Back?

V I S I O N South Wolf Road, Wheeling, IL

direct Assistant: Jeanne Tomazin

FMI Prefabrication Forum. The Changing Face of Engineering & Construction

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

Make Your Brand Attractive To Private Equity Funds Investing In Emerging Restaurant Companies

Transcription:

MERGERS & ACQUISITIONS CAPITAL RAISES FINANCIAL & STRATEGIC ADVISORY HEALTHCARE SERVICES MARKET UPDATE SPRING 2018 TRENDS & COMMENTARY The Song Remains the Same The number of healthcare services M&A transactions for the full year 2017 remained flat compared to 2016 at just under 1,000 deals announced. Dollar volume was noticeably higher, coming in at $176B compared to $71B in 2016; however, most of the difference is attributed to CVS Health s monster $77B acquisition of Aetna. This transformative deal best exemplifies the tectonic movement created from the energy of value-based care atop the ever-rising magma of delivery costs. Provider, payor and service provider business models are colliding and converging at an accelerated pace as controlling patient outcomes across the care continuum and containing risk take center stage. Somewhere Henry J. Kaiser is nodding. Buy Two and Call Me in the Morning Hospital and Health System transaction volume cooled a bit in 2017, although the size of deals as measured in beds per facility hit a 10-year high as mergers between larger, regional systems picked up steam. Consolidation of hospital-based physician groups continues to follow suit the large practice management companies remain in the driver seat for emergency medicine, anesthesiology and radiology groups seeking a larger house; however, private equity remains a competitive option for practices of scale. Outside the hospital, private equity spending on specialty physician groups in 2017 reached levels that would make a drunken sailor blush. Transaction volume was up over 25% from 2016 and multiples sit at alltime highs for scalable practices in dermatology, dentistry, radiology and orthopedics. Activity in the gastro, pain management and vision markets is not far behind. Primary care physician groups are even getting institutional attention. 2018 is showing no signs of a hangover so there s no need to call a Doctor just yet unless of course you re looking to buy his or her practice. CHILDSCONNECT CONFERENCE Our 9 th annual conference, CHILDSConnect, will be on May 10th in Atlanta at The St. Regis Hotel in Buckhead. Over 400 owners, executives, and investors interested in middle market growth opportunities are registered to attend. Key Note Presentation Amazon: Frenemy or Foe? Presented by Clay Cowen, McKinsey Partner in Marketing Practice, and Steve Stafford, McKinsey Senior Advisor Highlights Unique and valuable network opportunities Five sector updates: Healthcare, HCM, Industrial Services, IT & Professional Services, and Software Middle market M&A trends Roundtable discussions Learn More & Register www.childsadvisorypartners.com/childsconnect CHILDS HEALTHCARE SERVICES TRANSACTION SPOTLIGHT CHILDS Advisory Partners served as the exclusive financial advisor to Gwinnett Emergency Specialists, P.C. ( GES or the Company ), an emergency medicine physician group practice located in Lawrenceville, GA, in its sale to Envision Physician Services, a division of Envision Healthcare Corporation (NYSE: EVHC). Since its inception, GES has provided emergency medicine services for the Gwinnett Medical Center. Today, over 70 highly-trained professionals provide emergency and observation care for GMC s two acute care hospitals which generate over 150,000 patient visits per year. Combined, these facilities include a Level II Trauma Center, a full-service Emergency Center, a dedicated Children s Emergency Center and a 20-bed Observation Unit. Ross DeDeyn rdedeyn@childsap.com 404-461-4618 Ryan Sugrue Vice President rsugrue@childsap.com 404-461-4619 Charlie Lockwood Associate clockwood@childsap.com 404-461-4617 1

HEALTHCARE SERVICES COVERAGE & TRANSACTIONS CHILDS HEALTHCARE SERVICES SEGMENT COVERAGE P ROVIDER S ERVICES P HARMA S ERVICES PRACTICE MANAGEMENT OUTPATIENT C ARE Equipment Maintenance Clinical Trial Management Anesthesiology Behavioral Health Diagnostic Lab Services CMPOs / CDMOs Emergency Medicine Diagnostic Imaging Revenue Cycle Mgmt. Staffing / Recruiting Transport / Logistics Contract Research Distribution / Logistics Staffing / Recruiting Dentistry / Dermatology Ophthalmology Radiology Home Health Physical Therapy Surgery & Urgent Care CHILDS RECENT HEALTHCARE SERVICES TRANSACTIONS recapitalized by a portfolio company of Gridiron Capital Oct 2017 Jul 2017 May 2017 Jan 2017 Jan 2017 NOTABLE HEALTHCARE SERVICES TRANSACTIONS: Q4-2017 & Q1-2018 recapitalized by March 2018 March 2018 March 2018 February 2018 recapitalized by January 2018 January 2018 December 2017 December 2017 2

Deal Volume CHILDS Advisory Partners HEALTHCARE SERVICES M&A ACTIVITY AND TRENDS 450 PUBLIC MARKET INDEXED STOCK PERFORMANCE M&A VALUATIONS EV/EBITDA 350 1 16.0x 14.0x 12.7x 15.7x 13.8x 14.9x 250 12.0x 10.0x 7.3x 9.1x 150 6.0x 4.0x 2.0x 50 Mar-13 Sep-13 Mar-14 Sep-14 Mar-15 Sep-15 Mar-16 Sep-16 Mar-17 Sep-17 Mar-18 Outpatient Care Provider Services Hospitals Pharma Services S&P 500 2012 2013 2014 2015 2016 2017 PUBLIC MARKET EV/EBITDA INDEX PUBLIC MARKET VALUATIONS 20.0x 17.0x 14.0x 1 16.0x 14.0x 12.0x EV/EBITDA 13.9x 12.8x 13.7x 12.6x 13.4x 12.9x 12.3x 12.3x 16.7x 16.2x 15.8x 14.8x 11.0x 10.0x 7.8x 8.2x 8.1x 6.0x 4.0x 5.0x 2.0x 2.0x Mar-13 Sep-13 Mar-14 Sep-14 Mar-15 Sep-15 Mar-16 Sep-16 Mar-17 Sep-17 Mar-18 Outpatient Care Provider Services Hospitals Pharma Services S&P 500 Outpatient Care Provider Services Hospitals Pharma Services Q4-2016 Q2-2017 Q3-2017 Q4-2017 QUARTERLY M&A DEAL VOLUME 300 250 200 150 100 179 183 196 218 229 216 266 262 244 262 239 247 271 233 249 239 50 - Q1-2014 Q2-2014 Q3-2014 Q4-2014 Q1-2015 Q2-2015 Q3-2015 Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Sources: Capital IQ and CHILDS proprietary database 3

HEALTHCARE PUBLIC TRADING STATISTICS HOSPITALS Average Company Name 3/31/18 Week High Value Revenue EBITDA % Margin Revenue EBITDA Revenue EBITDA Growth CAGR Community Health Systems, Inc. $3.96 37.7% $ 443.5 $ 14,413.5 $ 15,353.0 $ 901.0 5.9% 0.9x 15.7x * 1.1x 9.3x (14.1%) (6.3%) HCA Healthcare, Inc. 97.00 90.8% 34,165.1 68,248.1 43,614.0 8,186.0 18.8% 1.6x 8.3x 1.4x 7.6x 4.2% 5.7% Kindred Healthcare, Inc. 9.15 76.9% 836.4 4,180.5 6,034.1 420.7 7.0% 0.7x 9.9x 0.7x 5.0x * (16.3%) 6.3% LifePoint Health, Inc. 47.00 69.2% 1,832.0 4,788.0 6,291.4 669.5 10.6% 0.8x 7.2x 0.7x 6.3x (0.2%) 12.0% Tenet Healthcare Corporation 24.25 96.1% 2,451.9 19,329.9 19,179.0 2,259.0 11.8% 1.0x 1.1x 7.4x (3.3%) 4.9% Universal Health Services, Inc. 118.41 92.4% 11,162.6 15,196.8 10,409.9 1,728.1 16.6% 1.5x 8.8x 1.3x 6.5% 8.3% Mean 77.2% $ 16,813.6 $ 2,360.7 11.8% 1.1x 8.4x 1.0x 7.7x (3.9%) 5.1% Median 83.8% 12,881.4 1,314.5 11.2% 1.0x 8.3x 1.1x 7.6x (1.7%) 6.0% PROVIDER SERVICES Average Company Name 3/31/18 Week High Value Revenue EBITDA % Margin Revenue EBITDA Revenue EBITDA Growth CAGR Envision Healthcare Corporation $38.43 60.0% $ 4,596.6 $ 11,429.2 $ 7,819.3 $ 1,047.4 13.4% 1.5x 10.7x 1.3x 10.7x 122.7% 68.9% Healthcare Services Group, Inc. 43.48 77.4% 3,203.6 3,156.2 1,866.1 135.8 7.3% 1.7x 23.2x * 1.4x 17.0x * 19.3% 13.0% Laboratory Corporation of America Holdings 161.75 89.0% 16,482.3 22,948.5 10,205.9 1,983.3 19.4% 2.2x 11.5x 1.9x 10.1x 8.6% 19.3% MEDNAX, Inc. 55.63 80.0% 5,192.6 6,974.9 3,458.3 583.0 16.9% 2.0x 11.9x 1.7x 10.4x 7.4% 12.3% Quest Diagnostics Incorporated 100.30 88.8% 13,619.1 17,540.1 7,709.0 1,554.0 20.2% 2.3x 11.0x 2.2x 10.5x 2.6% 1.2% RadNet, Inc. 14.40 99.7% 694.5 1,260.7 922.2 118.5 12.9% 1.4x 9.5x 1.3x 7.9x 3.1% 8.7% Mean 82.5% $ 5,330.1 $ 903.7 15.0% 1.8x 10.9x 1.6x 9.9x 27.3% 20.6% Median 84.4% 5,583.7 815.2 15.1% 1.9x 11.0x 1.5x 10.4x 8.0% 12.7% PHARMA SERVICES Average Company Name 3/31/18 Week High Value Revenue EBITDA % Margin Revenue EBITDA Revenue EBITDA Growth CAGR Cardinal Health, Inc. $62.68 75.7% $ 19,725.8 $ 28,268.8 $ 132,614.0 $ 3,159.0 2.4% 0.2x * 8.9x * 0.2x * 8.4x * 3.8% 12.2% Catalent, Inc. 41.06 85.8% 5,474.1 7,877.2 2,299.7 461.0 20.0% 3.4x 17.1x 2.8x 12.3x 19.9% 7.6% Charles River Laboratories International, Inc. 106.74 89.7% 5,062.6 6,034.3 1,857.6 446.7 24.0% 3.2x 12.9x 2.6x 10.8x 11.9% 12.7% ICON Public Limited Company 118.14 94.8% 6,389.2 6,377.6 1,758.4 404.9 23.0% 3.6x 15.8x 2.6x 13.0x 5.2% 5.4% IQVIA Holdings Inc. 98.11 88.7% 20,433.4 29,902.4 8,060.0 1,699.0 21.1% 3.7x 17.5x 2.8x 12.4x 49.5% 24.6% PRA Health Sciences, Inc. 82.96 86.5% 5,292.1 6,451.3 1,948.4 339.1 17.4% 3.3x 19.0x 2.2x 12.9x 22.4% 15.4% Mean 87.5% $ 24,208.0 $ 1,681.1 19.0% 3.5x 17.0x 2.6x 12.3x 16.1% 12.2% Median 88.7% 2,299.7 461.0 21.1% 3.4x 17.3x 2.6x 12.4x 11.9% 12.2% OUTPATIENT CARE Average Company Name 3/31/18 Week High Value Revenue EBITDA % Margin Revenue EBITDA Revenue EBITDA Growth CAGR Acadia Healthcare Company, Inc. $39.18 72.1% $ 3,458.5 $ 6,653.6 $ 2,836.3 $ 580.9 20.5% 2.3x 11.5x 2.1x 9.7x 213.7% 41.3% Amedisys, Inc. 60.34 91.5% 2,050.6 2,054.2 1,508.6 128.3 8.5% 1.4x * 15.6x 1.3x 12.4x 6.2% 8.3% DaVita Inc. 65.94 81.7% 11,949.9 21,941.8 10,883.7 2,409.0 22.1% 2.0x 9.1x * 1.8x 9.6x 4.3% (5.2%) Encompass Health Corporation 57.17 96.4% 5,610.6 8,597.7 3,919.0 833.2 21.3% 2.2x 10.2x 1.9x 9.7x 6.5% NM LHC Group, Inc. 61.56 80.9% 1,913.7 2,126.3 1,062.6 89.7 8.4% 2.0x 23.7x * 1.1x 11.2x 16.1% 14.0% Surgery Partners, Inc. 17.15 71.3% 833.7 4,160.1 1,312.5 229.6 17.5% 3.2x 17.6x 2.2x 15.1x 16.0% 49.4% U.S. Physical Therapy, Inc. 81.30 92.9% 1,030.2 1,173.1 410.4 65.0 15.8% 2.9x 1 2.7x * 18.7x * 14.6% 10.9% Mean 83.8% $ 3,133.3 $ 619.4 16.3% 2.4x 14.6x 1.7x 11.3x 39.6% 19.8% Median 81.7% 1,508.6 229.6 17.5% 2.3x 15.6x 1.9x 10.5x 14.6% 12.4% Source: Capital IQ $ in millions except for Share Price values * Denotes values excluded from the mean and median 4

EXTENSIVE HEALTHCARE SERVICES EXPERIENCE Sell-side advisor to Cirrus Medical Staffing on its sale to Webster Capital Travel nurse staffing services with unique international back office operations Sell-side advisor to Accountable Healthcare Staffing on its recapitalization with Mitsui & Co. Healthcare staffing services to hospitals and other outpatient facilities Sell-side advisor to Gwinnett Emergency Specialists on its sale to Envision Healthcare Emergency medicine practice serving 150,000 annual visits in greater Atlanta market Sell-side advisor to Trinity Healthcare Staffing Group on its sale to Travel Nurse Across America Travel nurse staffing and workforce management services Sell-side advisor to PharmaLogics Recruiting on its recapitalization with Webster Capital Recruitment Process Outsourced services to global life sciences market Sell-side advisor to Travel Nurse Across America on its recapitalization with Gridiron Capital Travel nurse staffing services, including training & testing, to US hospitals Sell-side advisor to HMS Consulting Group on its sale to HCTec Workforce management solutions for the healthcare industry Sell-side advisor to InterMed on its recapitalization with Wafra Partners Medical equipment management services to US hospitals Sell-side advisor to McKinnis on its sale to Navigant Revenue cycle management consulting services to US healthcare organizations Sell-side advisor to Advanced Medical on its recapitalization with Clearview Capital Occupational, physical and speech therapy staffing solutions Sell-side advisor to aspen advisors on its sale to The Chartis Group HCIT consulting, implementation and optimization services Sell-side advisor to ScribeAmerica on its recapitalization with Chicago Growth Partners Medical scribe education, training and managed services to hospitals Sell-side advisor to locum leaders on its sale to Onward Healthcare Physician staffing services to US healthcare systems and practice management organizations Sell-side advisor to Sharp Packaging on its sale to UDG Healthcare Outsourced pharmaceutical primary and secondary packaging services Sell-side advisor to Nursefinders on its recapitalization with Goldman Sachs UIG Travel and per diem healthcare staffing services to US hospitals Sell-side advisor to NLS Animal Health on its sale to Henry Schein National distributor of veterinary medicine pharmaceuticals 5

FIRM OVERVIEW QUICK FACTS 47 professionals across four offices in the U.S. with headquarters in Atlanta 84 Closed Transactions Since Beginning of 2014 Over 450 Middle Market Transactions Completed (EV less than $1B) 60% financial / 40% strategic buyer mix Market-leading close rate ACCOLADES 2016 US Boutique Investment Bank of the Year Winner 2014 Cross-Border Transaction of the Year Finalist 2014 Professional Services Transaction of the Year Finalist 2013 Strategic Acquisition of the Year Winner CORE COVERAGE SERVICES INDUSTRIAL HEALTHCARE HUMAN CAPITAL MERGERS & ACQUISITIONS CAPITAL RAISES FINANCIAL ADVISORY TECHNOLOGY HEALTHCARE SERVICES TEAM Ross DeDeyn Cooper Mills Jason Wallace Dave Phillips Former healthcare investment banker with UBS and Piper Jaffray 15 years of investment banking experience JD from University of Georgia School of Law and MBA from Columbia Business School Founded and led Robinson- Humphrey s Business Services practice starting in 1992 Executed over 100 Professional Services transactions MBA from Darden School of Business at University of Virginia Former for Blackstone Advisory Partners, the M&A advisory arm of Blackstone 20 years of investment banking experience, executing $40B+ of M&A transactions MBA from Harvard Business School Former executive at MPS Group and Volt Information Sciences Sourced and executed over 50 Professional Services transactions Focuses on corporate and business development strategy Steve Dyott Director Prior corporate finance and restructuring experience with FTI Consulting Over 10 years of investment banking experience BS in Economics from Vanderbilt University, summa cum laude Ryan Sugrue Vice President Prior M&A experience with Piper Jaffray JD from University of Georgia School of Law and MBA from Terry College of Business at the University of Georgia Robert Womble Vice President Prior M&A experience with FMI Capital Advisors Over 6 years of investment banking experience BS in Business Administration from Washington & Lee University 3550 Lenox Road NE, Suite 1200, Three Alliance Center Atlanta, GA 30326 404.461.4600 www.childsadvisorypartners.com 6